Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
JRS PHARMA's top competitor, Perrigo, earned an annual revenue of $4.4B.
JRS PHARMA's smallest competitor is Axygen with revenue of $240.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Nostrum Laboratories | $77,111 | $15.0M | 148 | - |
| Akorn | $62,397 | $682.4M | 2,227 | - |
| Cadista Pharmaceuticals | $51,563 | $75.0M | 200 | - |
| West-Ward Pharmaceuticals | $59,065 | $150.0M | 249 | 62 |
| Qualitest Pharmaceuticals | $44,685 | $230.0M | 7,500 | - |
| Aphena Pharma Solutions | $50,277 | $9.5M | 107 | 11 |
| PharmaAssociatesInc | $63,321 | $63.2M | 29 | - |
| Reed-Lane | $47,698 | $18.8M | 125 | - |
| NOW Foods | $46,473 | $360.0M | 985 | 40 |
| Axygen | $54,155 | $240,000 | 200 | - |
Zippia gives an in-depth look into the details of JRS PHARMA, including salaries, political affiliations, employee data, and more, in order to inform job seekers about JRS PHARMA. The employee data is based on information from people who have self-reported their past or current employments at JRS PHARMA. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by JRS PHARMA. The data presented on this page does not represent the view of JRS PHARMA and its employees or that of Zippia.
JRS PHARMA may also be known as or be related to JRS PHARMA, JRS Pharma, JRS Pharma LP and Jrs Pharma.